Evidence for stunned myocardium in humans: A 2001 update

Coronary Artery Disease

Volumn 12, Issue 5, 2001, Pages 349-356

  Kloner, R A ^a   Arimie, R B ^a   Kay, G L ^a   Cannom, D ^a   Matthews, R ^a   Bhandari, A ^a   Shook, T ^a   Pollick, C ^a   Burstein, S ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Cardioversion; Myocardial infarct; Myocardial ischemia; Myocardial stunning; Neurogenic stunning

Indexed keywords

ANGINA PECTORIS; ANGIOPLASTY; CARDIOVERSION; CLINICAL FEATURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STUNNED HEART MUSCLE;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIAC SURGICAL PROCEDURES; CENTRAL NERVOUS SYSTEM; ELECTRIC COUNTERSHOCK; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034913797     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200108000-00003     Document Type: Review

References (74)

1. The stunned myocardium - Prolonged, post-ischemic ventricular dysfunction
2. Coronary reperfusion for the treatment of acute myocardial infarction: Post ischemic ventricular dysfunction
3. Perspective. Myocardial reperfusion: A double-edged sword?
4. Superoxide dismutase plus catalase improves contractile function in the canine model of the "stunned myocardium"
5. Postischemic myocardial "stunning": A clinically relevant phenomenon
6. Altered myocardial states: The stunned and hibernating myocardium
7. Myocardial stunning and hibernation: Mechanisms and clinical implications
8. Myocardial "stunning" in man
9. Basic and clinical aspects of myocardial stunning
10. Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease
11. Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning
12. Stunned myocardium. Historical perspective
13. Effect of verapamil on postischemic "stunned" myocardium: Importance of timing of treatment
14. Nifedipine administered post reperfusion ablates systolic contractile dysfunction of postischemic "stunned" myocardium
15. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure radius relations
16. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography
17. Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: A possible manifestation of myocardial stunning
18. Exercise echocardiography: A clinically practical addition in the evaluation of coronary artery disease
19. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease
20. Myocardial stunning: A post ischemic syndrome with delayed recovery
21. Persistence of regional left ventricular dysfunction after exercise-induced myocardial ischemia
22. Quantitative echocardiography in assessing myocardial stunning in humans following exercise testing
23. Advantages and applications of the centerline method for characterizing regional ventricular function
24. Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease
25. Symptom-limited exercise testing causes sustained diastolic dysfunction in patients with coronary disease and low effort tolerance
26. The effect of exercise-induced myocardial ischemia on postischemic left ventricular diastolic filling
27. Significance of persistent left ventricular dysfunction during recovery after dobutamine stress echocardiography
28. Transient prolonged stunning induced by dipyridamole and shown on 1- and 24-hour poststress 99m-Tc-MIB1 gated SPECT
29. Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide mononitrate on the time course and severity of exercise-induced myocardial stunning
30. The "wavefront phenomenon" of myocardial ischemic cell death II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow
31. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion
32. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction
33. Intracoronary infusion of streptokinase in patients with acute myocardial infarction. Effects of reperfusion on left ventricular performance
34. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: A tomographic assessment using two-dimensional echocardiography
35. Early recovery of regional left ventricular function after reperfusion in acute myocardial infarction assessed by serial two-dimensional echocardiography
36. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction
37. Evolution of left ventricular function after intracoronary thrombolysis for acute myocardial infarction
38. Prospective identification of myocardial stunning using technetium-99m sestamibi-based measurements of infarct size
39. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation
40. Inotropic stimulation of reperfused myocardium: Effects on infarct size and myocardial function
41. Medical and cellular implications of stunning, hibernation, and preconditioning. An NHLBI Workshop
42. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and post-extrasystolic potentiation
43. The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction
44. Clinical evidence for stunned myocardium after coronary artery bypass surgery
45. Scintigraphic and hemodynamic demonstration of transient left ventricular dysfunction immediately after uncomplicated coronary artery bypass grafting
46. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery
47. An accurate nontraumatic ultrasonic method to monitor myocardial wall thickening in patients undergoing cardiac surgery
48. Sequential postoperative assessment of left ventricular performance with gated cardiac blood pool imaging following aortocoronary bypass surgery
49. Serial assessment of left ventricular performance following coronary artery bypass grafting
50. Biventricular function after myocardial revascularization in humans: Deterioration and recovery patterns during the first 24 hours
51. Delayed recovery of severely "stunned" myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgery
52. Neurogenic cardiac surgery after subarachnoid hemorrhage
53. Myocardial injury and left ventricular performance after subarachnoid hemorrhage
54. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: An echocardiographic study
55. Neurogenic stunned myocardium in Guillain-Barré syndrome
56. Functional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning
57. Stunned myocardium after hip arthroplasty
58. Myocardial stunning in hyperthyroidism
59. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography
60. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events
61. Impaired left atrial mechanical function after cardioversion: Relation to duration of atrial fibrillation
62. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation. Evidence for "atrial stunning" as a mechanism of thromboembolic complications
63. Left atrial chamber and appendage function after internal atrial defibrillation. A prospective and serial transesophageal echocardiographic study
64. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation
65. Myocardial injury after electrical therapy for cardiac arrhythmias assessed by tropinin-T release
66. Metabolic changes and mitochondrial dysfunction early following transthoracic countershocks in dogs
67. Cardiac tropinin I does not increase after cardioversion
68. Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter
69. Reversible left ventricular dysfunction. Does it affect clinical practice and does it matter
70. Methods of assessment and clinical relevance of myocardial hibernation and stunning. Assessment of myocardial viability
71. Myocardial stunning, hibernation, and ischemic preconditioning
72. "Myocardial stunning". Remaining questions
73. Left ventricular dysfunction due to the new ischemic outcomes. Stunning and hibernation
74. Characterization of hibernating and stunned myocardium